Examination Report |
1 | Power of Attorney | 25 Apr 2016 |
10 | Annexure -1 under rule 46 | 25 Sep 2018 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 25 Sep 2018 |
11 | Evidence Affidavit Under Rule 45 (TOP) | 29 Oct 2018 |
12 | Evidence Affidavit Under Rule 46 (TOP) | 24 Dec 2018 |
13 | Annexure -1 under rule 46 | 24 Dec 2018 |
2 | TM-1 | 25 Apr 2016 |
3 | Reply to Exam Report (MIS-R) | 28 Oct 2016 |
4 | TM-O(NOTICE OF OPPOSITION) | 03 Nov 2017 |
5 | Journal Copy | 22 Jan 2018 |
6 | TM-O(NOTICE OF OPPOSITION) | 24 Jan 2018 |
7 | Opponents Affidavit Rule | 26 Jul 2018 |
8 | Correspondence | 12 Sep 2018 |
9 | Annexure -1 under rule 46 | 25 Sep 2018 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 25 Sep 2018 |
1 | QR Examination Report for : 3242533 | 4156746 | 27 Oct 2016 | |
2 | Opposition Notice | 5863050 | 2509903 | 08 Feb 2018 |
3 | Opposition Notice | 6345322 | 2777372 | 11 May 2018 |
4 | Opposition Counter Statement | 6503519 | 2899659 | 14 Jun 2018 |
5 | Opposition Counter Statement | 6891456 | 3139503 | 29 Aug 2018 |
The application for Prolosin was made on 25 April 2016.
The trademark applicant for Prolosin is EMCURE PHARMACEUTICALS.
Prolosin is applied in class(es) 5.
Application for Prolosin is on Opposed stage.
Application Id allotted to Prolosin is 3242533.
Trademark agent or attorney for the application is Aditya & Associates.
Prolosin filed with the Intellectual property office as a WORD.